NCT04723238View on ClinicalTrials.gov

Bioavailability of Duloxetine 60 mg With Regards to Reference Product in Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

January 23, 2021

Primary Completion Date

February 9, 2021

Study Completion Date

March 26, 2021

Conditions
Bioequivalence
Interventions
DRUG

Duloxetine 60mg Test Drug Enteric Coated Granules

Investigational Medicinal Product

DRUG

Duloxetine 60mg Reference Product Enteric Coated Granules

Cymbalta (Eli Lilly)

Trial Locations (1)

7510491

Innolab, Santiago

Sponsors
All Listed Sponsors
lead

Laboratorios Andromaco S.A.

INDUSTRY

NCT04723238 - Bioavailability of Duloxetine 60 mg With Regards to Reference Product in Fasting Conditions | Biotech Hunter | Biotech Hunter